Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences - PubMed (original) (raw)

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences

C Power et al. J Virol. 1994 Jul.

Abstract

Human immunodeficiency virus (HIV) dementia is a common clinical syndrome of uncertain pathogenesis in patients with AIDS. In several animal models of retrovirus-induced brain disease, specific viral envelope sequences have been found to influence the occurrence of central nervous system disease. Therefore, to search for unique envelope sequences correlated with HIV dementia, we studied 22 HIV-infected patients who were neurologically assessed premortem and classified into demented (HIVD) (n = 14) and nondemented (ND) (n = 8) groups. Using DNA from autopsied brain and spleen, we amplified, cloned, and sequenced a 430-nucleotide region including the V3 loop and flanking regions. All brain-derived clones in both clinical groups showed marked homology to the macrophage-tropic consensus sequence within the V3 loop. Two amino acid positions within (position 305) and outside (position 329) the V3 region showed significant divergence between the two clinical groups. At position 305, a histidine was predominant in the HIVD group and was not observed in the ND group, but a proline was predominant in the ND group and was not observed in the HIVD group. Similarly, at position 329, a leucine was predominant in the HIVD group but rarely observed in the ND group, whereas an isoleucine was predominant in the ND group at this position. In addition, the HIVD group had 21 amino acid residues at specific positions that were unique relative to the ND group, whereas only 2 residues at specific positions were unique to the ND group. These data suggest that distinct HIV envelope sequences are associated with the clinical expression of HIV dementia.

PubMed Disclaimer

Similar articles

• Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients.
  Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, Chesebro B. Power C, et al. J Virol. 1998 Nov;72(11):9045-53. doi: 10.1128/JVI.72.11.9045-9053.1998. J Virol. 1998. PMID: 9765449 Free PMC article.
• Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
  Bruce C, Clegg C, Featherstone A, Smith J, Biryahawaho B, Downing R, Oram J. Bruce C, et al. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543-50. doi: 10.1089/aid.1994.10.1543. AIDS Res Hum Retroviruses. 1994. PMID: 7888209
• HIV type 1 V3 sequences and the development of dementia during AIDS.
  Di Stefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F. Di Stefano M, et al. AIDS Res Hum Retroviruses. 1996 Apr 10;12(6):471-6. doi: 10.1089/aid.1996.12.471. AIDS Res Hum Retroviruses. 1996. PMID: 8679301
• [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
  Gómez Carrillo M, Piccardo C, Libonatti O. Gómez Carrillo M, et al. Rev Argent Microbiol. 1992 Apr-Jun;24(2):91-101. Rev Argent Microbiol. 1992. PMID: 1298019 Spanish.
• Antigenic and immunogenic sites of HIV-2 glycoproteins.
  Chiodi F, Björling E, Samuelsson A, Norrby E. Chiodi F, et al. Chem Immunol. 1993;56:61-77. doi: 10.1159/000319156. Chem Immunol. 1993. PMID: 8452654 Review.

Cited by

• The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.
  Navia BA, Rostasy K. Navia BA, et al. Neurotox Res. 2005 Oct;8(1-2):3-24. doi: 10.1007/BF03033817. Neurotox Res. 2005. PMID: 16260383 Review.
• Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.
  Avdoshina V, Biggio F, Palchik G, Campbell LA, Mocchetti I. Avdoshina V, et al. Glia. 2010 Oct;58(13):1630-9. doi: 10.1002/glia.21035. Glia. 2010. PMID: 20578038 Free PMC article.
• Pathogenic mechanisms of neuronal damage in the AIDS dementia complex.
  Swingler S. Swingler S. Mol Pathol. 1997 Apr;50(2):72-6. doi: 10.1136/mp.50.2.72. Mol Pathol. 1997. PMID: 9231153 Free PMC article. Review. No abstract available.
• Novel mechanisms of central nervous system damage in HIV infection.
  Hazleton JE, Berman JW, Eugenin EA. Hazleton JE, et al. HIV AIDS (Auckl). 2010;2:39-49. doi: 10.2147/hiv.s9186. Epub 2010 Mar 11. HIV AIDS (Auckl). 2010. PMID: 22096383 Free PMC article.
• Apoptosis induced by HIV-1 infection of the central nervous system.
  Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, Gabuzda D. Shi B, et al. J Clin Invest. 1996 Nov 1;98(9):1979-90. doi: 10.1172/JCI119002. J Clin Invest. 1996. PMID: 8903316 Free PMC article.

References

1. 1. J Virol. 1987 Apr;61(4):1037-44 - PubMed
2. 1. Nature. 1994 Jan 13;367(6459):188-93 - PubMed
3. 1. Medicine (Baltimore). 1987 Nov;66(6):407-37 - PubMed
4. 1. Acta Neuropathol. 1988;76(4):373-9 - PubMed
5. 1. J Infect Dis. 1988 Nov;158(5):1079-83 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • LANL HIV Databases